Chronic Myeloproliferative Disorders Active Not Recruiting Phase 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00544115Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersTreatment
NCT00448201Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseTreatment